基石控股(01592.HK)與翰林擬建立戰略合作伙伴關係
格隆匯 4 月 15日丨基石控股(01592.HK)宣佈,於2020年4月15日,公司與翰林國際控股有限公司("翰林")訂立戰略合作框架協議,內容有關進行多箇中國市場分部開發的業務合作,包括用作提高銷售及營運效率以及興建新基礎設施的大數據工具O2O商城。
根據框架協議,公司與翰林擬建立戰略合作伙伴關係,以於多箇中國市場分部實現新型應用,包括用作提高銷售及營運效率以及興建新基礎設施的大數據工具O2O商城。在緊密戰略合作中,公司將與翰林進一步加強各自的優勢,提高營運效率,實現互惠互利的戰略。公司可能會動用內部資源以研究戰略合作的可行性。框架協議將有效直至2021年12月31日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.